Ads
related to: novel biomarkers in breast cancer research foundation
Search results
Results From The WOW.Com Content Network
She created a breast cancer biomarker discovery program that demonstrated the association between hormones, lifestyle factors, and cancer risk. [ 2 ] [ 5 ] Her research demonstrated that women who used hormone replacement therapy were more likely to suffer from breast cancer than women who did not, and that the risk was highest amongst women ...
Her research team subsequently became the first to show that RhoC was also involved in breast cancer and could transform cells into cancerous ones with metastatic potential. [9] Later, Merajver's research team used experimental data from the MAPK/ERK pathway to develop a new mathematical model for scientists to learn which cellular processes ...
While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, AFP (liver cancer), BCR-ABL (chronic myeloid leukemia), BRCA1 / BRCA2 (breast/ovarian cancer), BRAF V600E (melanoma/colorectal cancer), CA-125 ...
Supported by Cancer Research UK and The Mark Foundation through the Cancer Grand Challenges program, a global team of researchers explored key questions about cancer biology over five years. Their ...
Moses has investigated what regulates these cancer-promoting genes, [3] and the molecular-level differences between dormant and active tumors. [4] Her research used quantitative phase imaging to visually track cells that were moving out of a state of dormancy into an active state, [ 5 ] and examined how a protein found in cartilage can block ...
The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. [1] BCRF currently funds over 255 researchers in 14 countries. [2]
Ads
related to: novel biomarkers in breast cancer research foundation